Does APATINIB Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with APATINIB. This represents 3.2% of all adverse event reports for APATINIB.
5
Reports of Malignant neoplasm progression with APATINIB
3.2%
of all APATINIB reports
4
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From APATINIB?
Of the 5 reports, 4 (80.0%) resulted in death, 1 (20.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APATINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does APATINIB Cause?
Myelosuppression (30)
Palmar-plantar erythrodysaesthesia syndrome (28)
Proteinuria (23)
Fatigue (22)
Rash (21)
Hypertension (20)
Anaemia (19)
Diarrhoea (17)
Decreased appetite (15)
Leukopenia (15)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which APATINIB Alternatives Have Lower Malignant neoplasm progression Risk?
APATINIB vs APIDRA
APATINIB vs APIDRA SOLOSTAR
APATINIB vs APIXABAN
APATINIB vs APOMORPHINE
APATINIB vs APRACLONIDINE